课题基金 / 基金详情

Characterization of tumorigenic features of uterine leiomyoma

Characterization of tumorigenic features of uterine leiomyoma
子宫肌瘤致瘤特征的表征
批准号:
08457438
负责人:
FUJII Shingo
金额:
$4.74万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

FUJII Shingo的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The mechanisms regarding to the shrinkage of leiomyoma during the treatment with GnRH analogue (GnRH) analogue have been investigated using this in vitro system of uterine leiomyoma. Previously, we demonstrated that the cells from leiomyoma formed ball-like aggregations which we named "ball-like aggregations (BLAs)". Since the ball-like aggregations of cells from leiomyoma seem to be close to the features of uterine leiomyoma in vivo, this allows us to evaluate the efficiency of GnRH analogue currently used for chemotherapy of uterine leiomyomas. The results showed that the addition of GnRH analogue caused disappearance of the figure of the ball-like aggregations of cells from leiomyoma. The results also showed that GnRH directly binds to the cultured cells from leiomyoma and that the existence of GnRH receptor as well as GnRH expression in the cells from leiomyomas. Furthermore, the addition of small and short doses of GnRH analogue stimulates the proliferation of smooth muscle cells … More of leiomyoma, but the late G1 phase cell cycle related genes' expression were suppressed by the addition of high doses GnRH analogue for long treatment. These results suggested that GnRH analogue may directly regulate the growth of uterine leiomyomas, and that the in vivo system of uterine leiomyoma is useful to evaluate the efficiency of drugs currently used for chemotherapy of uterine leiomyomas. Mast cells (MCs) are widely distributed in most human tissues and neoplasms, including a leiomyoma. GnRHa has been recently applied for the treatment of a leiomyoma. To elucidate the role of MCs in a leiomyoma, the relationship between the number of MCs in leiomyomas and the histological features was analyzed, furthermore, the number of MCs in untreated leiomyomas was compared with that of MCs in the leiomyomas treated with GnRHa. The results showed that the number of MCs in untreated leiomyomas was widely distributed, but there were more Mcs in leiomyomas with fewer collagen matrix, with higher cellularity, and with high intensity of T2 weighted MR image. In addition, the leiomyomas which had highly shrinked with GnRHa contained a larger number of MCs, and these MCs were not increased by GnRHa, but before therapy they had existed in the leiomyomas The findings suggest that MCs may associated with prolierative activity of leiomyoma and play a role in shirnkage of the size in GnRHa therapy.Both ER and PR are immunohistochemically expressed in all ULs. PR was definitely experssed in UL irrespective of the phase of the menstrual cycle. This staining pattern of PR was also observed in CL,UMP and BL,although BL showed variable staining for ER.Compared to these tumors, the expression of both ER and PR was markedly reduced in LMS.The results of ER and PR transcripts by RT-PCR amplification were compatible with those of immunohistochemistry. The number of Ki-67 positive cells in LMS was extraordinary and significantly higher than in UMP,BL,CL and UL.P53 immunoreactivity was seen Less
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
Shiozawa, T.et al: "Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type carsinomas." Cancer. 80・12. 2250-2256 (1997)
Shiozawa, T. 等人:“人类子宫内膜样癌中 cdk4 和 p16INK4 表达的免疫组织化学分析。”癌症 80·12 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Li, SF., Shiozawa, T., Nakayama, K., Nikaido, T., Fujii, S.: "Stepwise Abnormality of Sex Steroid Hormone Receptors, Tumor Suppressor Gene Products (p53 and Rb), and Cyclin E in Uterine Endometriloid Carcinoma." Cancer. 77 (2). 321-329 (1996)
Li, SF.、Shiozawa, T.、Nakayama, K.、Nikaido, T.、Fujii, S.:“子宫内膜样体中性类固醇激素受体、肿瘤抑制基因产物(p53 和 Rb)和细胞周期蛋白 E 的逐步异常
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kobayashi, Y., Zhai, Y.L., Iinuma, M., Horiuchi, A., Nikaido, T., Fujii, S.: "Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues" Molecular Human Reproduction. 3 (2). 91-99 (1997)
Kobayashi, Y.、Zhai, Y.L.、Iinuma, M.、Horiuchi, A.、Nikaido, T.、Fujii, S.:“GnRH 类似物对正常子宫肌层和子宫肌瘤组织培养的人平滑肌细胞的影响”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mori, A., Zhai, Y.L., Toki, T., Nikaido, T., Fujii, S.: "Distribution and heterogeneity of mast cells in the human uterus" Human Reproduction. 12 (2). 368-372 (1997)
Mori, A.、Zhai, Y.L.、Toki, T.、Nikaido, T.、Fujii, S.:“人类子宫中肥大细胞的分布和异质性”人类生殖。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
46
    Development of therapeutic and prophylactic method for the uterine smooth muscle tumors bu understanding novel aspect of its etiology
    Development of new therapeutic modalities based on the analysis of the pathogenesis and biological features of leiomyoma
    • 批准号:
      13307047
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.45万
    • 财政年份:
      2001
    • 负责人:
      FUJII Shingo
    • 依托单位:
    Comprehensive study about the neoplastic characterization of benign and malignant smooth muscle tumor arising in the uterus
    • 批准号:
      10470345
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.22万
    • 财政年份:
      1998
    • 负责人:
      FUJII Shingo
    • 依托单位:
    Reconsideration of Sex-steroid Receptor Regulatory Mechanism in the Female Genital Tract
    • 批准号:
      05454442
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.22万
    • 财政年份:
      1993
    • 负责人:
      FUJII Shingo
    • 依托单位: